Akanda Corporation - Kewajiban jangka dawa perusahaan AKAN

International medical cannabis producer Akanda (AKAN) is suffering from oversupply and collapsing prices, leading to massive losses and a lack of cash flow. Assets in Europe and Africa are cutting costs, but regulation is hindering profitability. The company's price evolution, where long-term debt is fixed at 0.00, is presented below. The market is closed to new players due to strict quotas and licensing requirements.

Long-term debt determines the stability of the capital structure and the business's ability to service obligations during expansion. This metric aggregates all loans with maturities exceeding one year, revealing the dependence on external financing. Monitoring the organization's long-term financial debt allows for an assessment of the risk of overpaying on interest. For Akanda (AKAN), this volume reflects investments in solar power generation and closed-loop irrigation systems. Such investments in ESG infrastructure require a precise balance between leveraged capital and liquidity.